×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
GlobeNewswire
TAMPA, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter...
1 day ago
Pacira Appoints Frank D. Lee as Chief Executive Officer
Yahoo Finance
Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and...
4 months ago
Pacira Hits Rivals With False Ad Suits Over Pain Drugs
Law360
Pharmaceutical company Pacira BioSciences Inc. is looking to stop rivals from marketing their so-called generic versions of its non-opioid...
5 months ago
Pacira publishes data showing Exparel reduces opioid use
Clinical Trials Arena
Exparel gained FDA approval for the expanded label to include sciatic nerve block in the popliteal fossa following these positive results.
2 months ago
Medical society takes millions from company that sued it for defamation – and lost
Retraction Watch
When the American Society of Anesthesiologists last October announced the receipt of a $2.5 million donation from a drug company – “to...
2 months ago
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
markets.businessinsider.com
Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions...
3 weeks ago
Pacira: Q4 Earnings Snapshot
Quartz
TAMPA, Fla. (AP) — TAMPA, Fla. (AP) — Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported fourth-quarter earnings of $24.9 million.
2 months ago
Nephron faces lawsuit over pain med competitor says it sold without FDA approval
The State
Lexington County-based Nephron Pharmaceuticals is being sued by another drug manufacturer, which claims Nephron products are being marketed...
4 months ago
NVS: Top 3 Pharma Stocks With Bullish Momentum
StockNews.com
Novartis AG(NYSE:NVS): The pharmaceutical industry's future appears increasingly optimistic, encouraged by surging healthcare spending due...
3 months ago
Pacira Touts Stability Upgrade In Pain Drug Patent Trial
Law360
A novel manufacturing process that extends the shelf life of the pain reliever Exparel should extend the exclusivity period of the product's...
2 months ago